Conferences

Catalog

Abstracts

Calendar

Philadelphia Hematologic Malignancies Conference 2026: Advances in Myeloma, Leukemia, Lymphoma & MDS Care

Accreditation: 6.50 ACPE Pharmacy | 6.50 Nursing Contact Hours | 6.50 ABIM MOC II | 6.50 AMA PRA Category 1 Credit™

Venue: Hilton Philadelphia City Avenue , 4200 City Avenue, Philadelphia, PA, United States

Start Date: September 26, 2026

Overview

Trusted by Thousands of Attendees
Across Our Events

20+

Email if you have questions

Our Speakers

Planning Committee

Binay Shah, MD, MHA

Conference Director

Binayatara

Catherine Lai, MD, MPH

Conference Co-Chair

Alfred Garfall, MD

Conference Co-Chair

University of Pennsylvania

Marco Ruella, MD

Conference Co-Chair

Faculty

Wyatt McCall, MD

Moderator

Luca Paruzzo

Topic Presenter

Abramson Cancer Center, University of Pennsylvania

Shazia Nakhoda, MD

Topic Presenter

Fox Chase Cancer Ctr

Ximena Jordan-Bruno , MD

Topic Presenter

Alexander R Vartanov, MD

Topic Presenter

Fox Chase Cancer Ctr

Daniel Jeffrey Landsburg, MD

Topic Presenter

Abramson Cancer Center, University of Pennsylvania

Peter Abdelmessieh, MD

Topic Presenter

Ubaldo E. Martinez Outschoorn, MD

Topic Presenter

Alexander Perl, MD

Topic Presenter

University of Pennsylvania

Margaret Kasner, MD

Topic Presenter

Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA

Lindsay Wilde, MD

Topic Presenter

Sandra Susanibar-Adaniya, MD, MD

Topic Presenter

University of Pennsylvania

Asya Varshavsky, MD

Topic Presenter

Adam Binder, MD

Topic Presenter

Lukas Ronner, MD

Topic Presenter

Hospital of the University of Pennsylvania

Jakub Svoboda, MD

Topic Presenter

Stephen J Schuster

Topic Presenter

Matthew Ho

Topic Presenter

Mathew Ho

Topic Presenter

Our Agenda

Saturday, September 26th, 2026

All timings are in Eastern Time (EDT, GMT-04:00) time.

07:00 AM - 08:00 AMRegistration, Breakfast, & Exhibits

08:00 AM - 08:10 AMWelcome

08:10 AM - 08:30 AMBinaytara's Efforts in Improving Cancer Care Disparities

08:30 AM - 09:50 AMSession 1: Myeloma

Session Chair: Alfred Garfall, MD

08:30 AM - 08:35 AM

Speaker Introductions

08:35 AM - 08:45 AM

Topic 1: Smoldering Multiple Myeloma: To Treat or Not to Treat? – Sandra Susanibar-Adaniya, MD, MD

08:45 AM - 08:50 AM

Q&A – Sandra Susanibar-Adaniya, MD, MD

08:50 AM - 09:00 AM

Topic 2: Who Should Receive High-Dose Melphalan and Autologous Stem Cell Transplant in 2026? – Asya Varshavsky, MD

09:00 AM - 09:05 AM

Q&A – Asya Varshavsky, MD

09:05 AM - 09:15 AM

Topic 3: Optimal Therapy for First Relapse: CAR-T Cells or Bispecific Antibodies? – Adam Binder, MD

09:15 AM - 09:20 AM

Q&A – Adam Binder, MD

09:20 AM - 09:50 AM

Case-Based Panel Discussion: Standard-Risk Patient with First Relapse – Mathew Ho

09:50 AM - 10:35 AMBreak & Exhibits

10:35 AM - 11:55 AMSession 2: Acute Leukemias and High Risk MDS

Session Chair: Catherine Lai, MD, MPH

10:35 AM - 10:40 AM

Speaker Introductions

10:40 AM - 10:50 AM

Topic 1: How I Treat Older Patients with Newly Diagnosed AML? – Margaret Kasner, MD

10:50 AM - 10:55 AM

Q&A – Margaret Kasner, MD

10:55 AM - 11:05 AM

Topic 2: The Newest Kid on the Block: Menin Inhibitors – Alexander Perl, MD

11:05 AM - 11:10 AM

Q&A – Alexander Perl, MD

11:10 AM - 11:20 AM

Topic 3: How I treat High-Risk MDS? – Alexander R Vartanov, MD

11:20 AM - 11:25 AM

Q&A – Alexander R Vartanov, MD

11:25 AM - 11:55 AM

Case Based Panel Discussion: TP53 mutated MDS/AML: To Transplant or not to Transplant? – Lukas Ronner, MD

11:55 AM - 01:15 PMSession 3: MPN/CML/Low Risk MDS

Session Chair: Catherine Lai, MD, MPH

11:55 AM - 12:00 PM

Speaker Introductions

12:00 PM - 12:10 PM

Topic 1: Which JAK Inhibitor do I use as Second Line in MF? – Peter Abdelmessieh, MD

12:10 PM - 12:15 PM

Q&A – Peter Abdelmessieh, MD

12:15 PM - 12:25 PM

Topic 2: How I Treat Transfusion Dependent Low-Intermediate Risk MDS? – Lindsay Wilde, MD

12:25 PM - 12:30 PM

Q&A – Lindsay Wilde, MD

12:30 PM - 12:40 PM

Topic 3: Which TKI should I use for Newly Diagnosed CML? – Ximena Jordan-Bruno , MD

12:40 PM - 12:45 PM

Q&A – Ximena Jordan-Bruno , MD

12:45 PM - 01:15 PM

Case-Based Panel Discussion: Optimal Treatment Sequencing in Low Risk MDS – Wyatt McCall, MD

01:15 PM - 02:15 PMLunch & Exhibits

02:15 PM - 03:50 PMSession 4: Aggressive Lymphomas (B&T)

Session Chair: Marco Ruella, MD

02:15 PM - 02:20 PM

Speaker Introductions

02:20 PM - 02:30 PM

Topic 1: How Frontline Treatment for LBCL is Evolving – Daniel Jeffrey Landsburg, MD

02:30 PM - 02:35 PM

Q&A – Daniel Jeffrey Landsburg, MD

02:35 PM - 02:45 PM

Topic 2: Management of r/r LBCL – Ubaldo E. Martinez Outschoorn, MD

02:45 PM - 02:50 PM

Q&A – Ubaldo E. Martinez Outschoorn, MD

02:50 PM - 03:00 PM

Topic 3: Feasibility of Novel Immunotherapies for NHL in Non-Tertiary Centers

03:00 PM - 03:05 PM

Q&A

03:05 PM - 03:15 PM

Topic 4: The Evolving Landscape of Therapies for T-Cell Lymphomas

03:15 PM - 03:20 PM

Q&A

03:20 PM - 03:50 PM

Case-Based Panel Discussion – Luca Paruzzo

03:50 PM - 05:10 PMSession 5: CLL and other Lymphomas

Session Chair: Marco Ruella, MD

03:50 PM - 03:55 PM

Speaker Introductions

03:55 PM - 04:05 PM

Topic 1: Are we Curing Follicular Lymphoma? – Stephen J Schuster

04:05 PM - 04:10 PM

Q&A – Stephen J Schuster

04:10 PM - 04:20 PM

Topic 2: How I treat CLL in 2026 – Shazia Nakhoda, MD

04:20 PM - 04:25 PM

Q&A – Shazia Nakhoda, MD

04:25 PM - 04:35 PM

Topic 3: Latest Updates on the Treatment of Hodgkin Lymphoma – Jakub Svoboda, MD

04:35 PM - 04:40 PM

Q&A – Jakub Svoboda, MD

04:40 PM - 05:10 PM

Case-Based Panel Discussion

05:10 PM - 05:10 PMAdjourn

About Philadelphia Hematologic Malignancies Conference 2026: Advances in Myeloma, Leukemia, Lymphoma & MDS Care

Overview

Faculty and committee

Our Speakers

Planning Committee

Faculty

Conference program and agenda

Our Agenda

Venue and map

Accreditations and continuing education

Registration and pricing

Exhibitors and sponsorship

Our Speakers

Planning Committee

Faculty

Our Agenda